(Q73566932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

S7-S64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Survival advantage in Asian American end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Reuse of dialyzers and clinical outcomes: fact or fiction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Predictors of the excessive mortality rates of dialysis patients in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of dialyzer reuse on survival of patients treated with hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

National surveillance of dialysis associated diseases in the United States, 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Dietary protein and energy requirements in ESRD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The hemodialysis pilot study: nutrition program and participant characteristics at baseline. The HEMO Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Dialysis patient outcomes in Europe vs the USA. Why do Europeans live longer?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Mortality and duration of hemodialysis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Status of hemodialysis adequacy in the United States: does it account for improved patient survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Trends in treatment and survival for hemodialysis patients in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

An international study of patient compliance with hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Urea index and other predictors of hemodialysis patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Assessing the adequacy of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effects of dose of dialysis on morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Inadequate dialysis increases gross mortality rate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Chronic dialysis treatment: clinical outcome and related processes of care

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The dose of hemodialysis and patient mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Quantitating hemodialysis: a comparison of three kinetic models

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Barriers to adequate delivery of hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 National ESRD Core Indicators Project

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Standardized hemodialysis prescriptions promote inadequate treatment in patients with large body mass.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Assessing adequacy of hemodialysis: urea modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Adequacy of hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Shortfalls in the delivery of dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Methodological limitations of the ESRD Core Indicators Project: an ESRD network's experience with implementing an ESRD quality survey. Medical Review Board of the ESRD Network of New England

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Variation in blood sample collection for determination of hemodialysis adequacy. Council on Renal Nutrition National Research Question Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Causes, kinetics and clinical implications of post-hemodialysis urea rebound

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of access recirculation on the modeled urea distribution volume.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The effect of dialyzer reuse on dialysis delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodialyzer reuse: estimation of area loss from clearance data

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Noncompliance in hemodialysis: predictors and survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Stimulation of mononuclear cells by contact with cuprophan membranes: further increase of beta 2-microglobulin synthesis by activated late complement components

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Dialysis-related amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Influence of high-flux biocompatible membrane on carpal tunnel syndrome and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Clinical implications of hemodialysis membrane biocompatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Role of bioincompatibility in dialysis morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Biocompatibility of dialysis membranes: Effects of chronic complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Complement Activation and Hypersensitivity Reactions to Dialysis Membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Adsorption of unactivated complement proteins by hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Depressed phagocytosis in hemodialyzed patients: in vivo and in vitro mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The role of dialysis membranes in infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Relationship between dialyser type and signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of the dialysis membrane on mortality of chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodialysis prescription and delivery in a metropolitan community. The St. Louis Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Accuracy of urea removal estimated by kinetic models

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Urea kinetic modeling: an in vitro and in vivo comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Determination of the solute removal index for urea by using a partial spent dialysate collection method

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Relationship between total body water and surface area in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Total body water volumes for adult males and females estimated from simple anthropometric measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Development of a population-specific regression equation to estimate total body water in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of reuse on dialyzer efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Mathematical modelling of haemodialysis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Paediatric haemodialysis: estimation of treatment efficiency in the presence of urea rebound

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Natural logarithmic estimates of Kt/V in the pediatric hemodialysis population.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Optimal care of the pediatric end-stage renal disease patient on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The impact of the Dialysis Outcomes Quality Initiative Guidelines on the care of the pediatric end-stage renal disease patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Linear estimates of variable-volume, single-pool Kt/V: an analysis of error

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Accuracy of the urea reduction ratio in predicting dialysis delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Survival as an index of adequacy of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Body weight-for-height relationships predict mortality in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis times

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Body size, dose of hemodialysis, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Kt/V is the best dialysis dose parameter

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Survival in dialysis and blood pressure control.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Role of volume overload in dialysis-refractory hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Postdialysis urea rebound: determinants and influence on dialysis delivery in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Urea kinetics during hemodialysis measured by microdialysis--a novel technique.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Comparative evaluation of different methods to estimate urea distribution volume and generation rate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Urea kinetic modeling at high urea clearances: implications for clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

A nomogram approach to hemodialysis urea modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodialysis urea rebound: the effect of increasing dialysis efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: urea output measurements compared with dietary protein intake and with calculation of urea generation rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Recirculation, urea disequilibrium, and dialysis efficiency: peripheral arteriovenous versus central venovenous vascular access

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Exploring the reverse J-shaped curve between urea reduction ratio and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Racial differences in the delivery of hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Recirculation reassessed: the impact of blood flow rate and the low-flow method reevaluated

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Screening for extreme postdialysis urea rebound using the Smye method: patients with access recirculation identified when a slow flow method is not used to draw the postdialysis blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Cardiopulmonary recirculation in dialysis. An underrecognized phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Cardiopulmonary recirculation during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Severe dialyzer dysfunction undetectable by standard reprocessing validation tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

In vivo measurement of hemodialyzer fiber bundle volume: theory and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodynamic study of hypotension during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Non-invasive monitoring of blood volume during hemodialysis: its relation with post-dialytic dry weight

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Influence of variation of ultrafiltration rate on cardiovascular stability during dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Acute symptoms during and between hemodialysis: the relative role of speed, duration, and biocompatibility of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Dialysis-induced alterations in left ventricular filling: mechanisms and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Interdialytic weight gain and nutritional parameters in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodynamic changes induced by regular hemodialysis and sequential ultrafiltration hemodialysis: A comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Comparison of vascular tone during combined haemodialysis with ultrafiltration and during ultrafiltration followed by haemodialysis: a possible mechanism for dialysis hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Vasoactive agents and blood pressure regulation in sequential ultrafiltration and hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The influence of dialysate sodium and variable ultrafiltration on fluid balance during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Preservation of plasma volume during hemodialysis depends on dialysate osmolality

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Plasma refilling during hemodialysis with decreasing ultrafiltration. Influence of dialysate sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Blood volume changes during three different profiles of dialysate sodium variation with similar intradialytic sodium balances in chronic hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Sodium ramping in hemodialysis: a study of beneficial and adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Acetate and bicarbonate fluctuations and acetate intolerance during dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Amelioration of hemodialysis-associated hypotension by the use of cool dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of dialysate temperature on central hemodynamics and urea kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effect of variations in dialysate temperature on blood pressure during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hemodialysis with Low-Temperature Dialysate: A Long-Term Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Effects of cooler temperature dialysate on hemodynamic stability in "problem" dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

The protective effect of cool dialysate is dependent on patients' predialysis temperature.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Postprandial blood pressure changes during hemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

Hypertension in the hemodialysis population: a survey of 649 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2801%2970005-4

7 January 2021

10.1016/S0272-6386(01)70005-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11229967%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference